Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

42
Delayed Quote. Delayed Nyse - 08/29 04:00:07 pm
55.28 USD   -0.58%
1d ago ABBVIE : Assigned Patent
08/26 ABBVIE : Testosterone Therapy Lawsuits: AndroGel Manufacturer Files Petitio..
08/25 Roche to buy U.S. biotech firm InterMune for $8.3 billion
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
55.87(c) 55.75(c) 55.7(c) 55.6(c) 55.28(c) Last
7 553 500 9 309 835 11 022 640 7 277 891 7 524 434 Volume
+1.21% -0.21% -0.09% -0.18% -0.58% Change
More quotes
Company
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
09/10 | 09:45amPresentation
Surperformance© rating of AbbVie Inc
Trading Rating : Investor Rating :
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 19 630 M
EBIT 2014 6 853 M
Net income 2014 4 722 M
Debt 2014 4 755 M
Yield 2014 2,99%
Sales 2015 21 714 M
EBIT 2015 8 606 M
Net income 2015 6 011 M
Debt 2015 1 500 M
Yield 2015 3,25%
PER 2014 19,45
PER 2015 13,38
EV / Sales 2014 4,73x
EV / Sales 2015 4,12x
Capitalization 88 034 M
More Financials
Latest news on ABBVIE INC
1d ago ABBVIE : Assigned Patent
08/26 ABBVIE : Testosterone Therapy Lawsuits: AndroGel Manufacturer Files Petition Aga..
08/25 Roche to buy U.S. biotech firm InterMune for $8.3 billion
08/24 ABBVIE : Project pilots a new way to deal with hepatitis C ; CORNWALL
08/22 ABBVIE : Assigned Patent
08/21 ABBVIE : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
08/21DJU.S. Restricts Narcotic Pain Drug Prescriptions
08/21DJInversions Push Falls to Treasury's Mark J. Mazur
08/21DJDEA Restricts Narcotic Pain Drug Prescriptions
08/21 ABBVIE : Cystic Fibrosis Scholarship Program Provides 40 Student Scholars with A..
08/18 ABBVIE : Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Ann..
08/18 ENANTA PHARMACEUTICALS : Updates on 3rd Quarter Financial Results
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
AbbVie Inc : Income Statement Evolution
More Financials
EPS Revisions
AbbVie Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF